About
Innovations to accelerate vaccine development and manufacture.
Inno4Vac is an interdisciplinary project funded by the Innovative Medicines Initiative 2 (IMI2) that aims to
· harness advances in the fields of immunology,
· big data and artificial intelligence,
· 3D tissue models and human infection models, and
· incorporate them into the vaccine industry to accelerate the development of new vaccines.
Start Date: 01/09/2021
End Date: 28/02/2027
Funding Agency: Innovative Medicines Initiative 2 (IMI2)
Coordinator: European Vaccine Initiative (EVI)
Total Funding: Public-private partnership, € 38.5 Mio (€ 18.6 Mio IMI, € 19.9 Mio EFPIA)
Contact details
Please sign in to see contact details.
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views
- Comments 0